Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems
暂无分享,去创建一个
[1] L. Beex,et al. Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance. , 1998, European journal of cancer.
[2] Mike Clarke,et al. Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[3] Mike Clarke,et al. Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[4] D. Allred,et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[5] R. Elledge,et al. Oestrogen receptors and breast cancer , 1997, BMJ.
[6] J. Elias. A Phoenix Arisen-Estrogen Receptor Immunohistochemistry , 1997 .
[7] D. Allred,et al. Estrogen receptor status (ER) determined by immunohistochemistry (IHC) is superior to biochemical ligand-binding (LB) assay for evaluating breast cancer patients , 1997 .
[8] D. Barnes,et al. Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. , 1996, British Journal of Cancer.
[9] J. Coindre,et al. pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients. , 1996, British Journal of Cancer.
[10] J. Feldman,et al. Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Spγ in frozen sections or cytosol‐based ligand‐binding assays , 1996, Cancer.
[11] M. Fernö,et al. Oestrogen receptor analysis of paraffin sections and cytosol samples of primary breast cancer in relation to outcome after adjuvant tamoxifen treatment. The South Sweden Breast Cancer Group. , 1996, Acta oncologica.
[12] S. Shousha,et al. Demonstration of oestrogen receptors in paraffin wax sections of breast carcinoma using the monoclonal antibody 1D5 and microwave oven processing. , 1994, Journal of clinical pathology.
[13] E. Wilkinson,et al. Comparison of two antibodies for evaluation of estrogen receptors in paraffin-embedded tumors. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[14] J. Coindre,et al. Production of monoclonal antibodies to human estrogen‐receptor protein (ER) using recombinant ER (RER) , 1993, International journal of cancer.
[15] M. Schemper,et al. Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer. , 1990, Cancer research.
[16] E. Szabo,et al. Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods. , 1989, Cancer research.
[17] E B Cox,et al. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. , 1985, Archives of pathology & laboratory medicine.